MD Anderson writes off $62M IBM Watson for Oncology deployment after five years

MD Anderson Cancer Center abandoned its 2012 partnership with IBM Watson for Oncology after spending approximately $62 million over five years, according to CIO.com. The write-off indicates that healthcare AI's primary bottleneck is integration with existing clinical infrastructure rather than model intelligence.

MD Anderson writes off $62M IBM Watson for Oncology deployment after five years According to CIO.com, MD Anderson Cancer Center abandoned its 2012 partnership with IBM Watson after spending approximately $62 million over five years, revealing that healthcare AI's primary bottleneck is integration with existing clinical infrastructure rather than model intelligence. Topics Sources - Press Read article https://www.cio.com/article/4223369/healthcare-ais-real-bottleneck-isnt-intelligence-its-integration/ Go deeper This intelligence is sourced automatically from public sources across the web and synthesised by the Prefactor AI pipeline. Stories are reviewed before publication.